Company profile
PYC Therapeutics (ASX: PYC)
Pioneering a new generation of RNA therapeutics to change the lives of patients with severe inherited diseases
- Industry
- Biotechnology
- Employees
- 69
- Headquarters
- San Francisco, CA
- Founded
- 2005
- LinkedIn followers
- 3,892
- Office locations
- 2
PYC Therapeutics (ASX: PYC) company summary
PYC Therapeutics (ASX: PYC) is a company in the Biotechnology industry, headquartered in San Francisco, CA, founded in 2005. On LinkedIn the company has around 69 employees and 3,892 followers. The company lists 2 office locations. Its listed specialties include RNA, Retinal disease, Rare disease, Cell-penetrating peptides, Retinitis Pigmentosa.
What technology does PYC Therapeutics (ASX: PYC) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About PYC Therapeutics (ASX: PYC)
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYC’s proprietary drug delivery technology. PYC's library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies including two programs focused on inherited eye diseases and preclinical discovery efforts focused on neurodegenerative diseases. PYC’s discovery and laboratory operations are located in Australia, and the Company’s preclinical and clinical operations are based in San Fransisco California.
Specialties
Where is PYC Therapeutics (ASX: PYC) located?
PYC Therapeutics (ASX: PYC) lists 2 office locations.
Compare companies similar to PYC Therapeutics (ASX: PYC)
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
PYC Therapeutics (ASX: PYC) pyctx.com | Biotechnology | 69 | 2005 | San Francisco, CA |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about PYC Therapeutics (ASX: PYC)
What does PYC Therapeutics (ASX: PYC) do?
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYC’s proprietary drug delivery technology. PYC's library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies including two programs focused on inherited eye diseases and preclinical discovery efforts focused on neurodegenerative diseases. PYC’s discovery and laboratory operations are located in Australia, and the Company’s preclinical and clinical operations are based in San Fransisco California.
How many employees does PYC Therapeutics (ASX: PYC) have?
PYC Therapeutics (ASX: PYC) has around 69 employees on LinkedIn.
Where is PYC Therapeutics (ASX: PYC) headquartered?
PYC Therapeutics (ASX: PYC) is headquartered in San Francisco, CA.
Where does PYC Therapeutics (ASX: PYC) have offices?
PYC Therapeutics (ASX: PYC) lists 2 office locations, including San Francisco, CA, US; Perth, Western Australia, AU.
When was PYC Therapeutics (ASX: PYC) founded?
PYC Therapeutics (ASX: PYC) was founded in 2005.
Build a lead list from companies like PYC Therapeutics (ASX: PYC)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.